A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma)
Clinical trial NCT05935891 · COMPLETED
Trial details
- NCT number
- NCT05935891
- Sponsor
- University of Minnesota
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2024-04-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.